INTC vs NVDA

Intel's deterministic health is stable with a Piotroski F-Score of 6/9, but this is overshadowed by a severe divergence between price and fundamentals. While the stock has seen a massive 1-year rally (+234.6%), the company is struggling with negative profit margins (-0.51%), declining revenue (-4.10%), and a catastrophic YoY EPS collapse of -300%. With the current price of $65.27 trading significantly above the analyst target of $55.33 and a technical trend score of 10/100, the stock appears overextended and fundamentally unsupported.

NVDA exhibits strong financial health with a Piotroski F-Score of 7/9, indicating robust operational efficiency and solvency. While the current price of $182.08 is significantly above the Graham Number ($26.71) and the growth-based intrinsic value ($144.55), the stock is fundamentally undervalued relative to its growth, as evidenced by a PEG ratio of 0.72 and a highly attractive Forward P/E of 16.38. The company's elite profitability margins (55.6% profit margin) and minimal debt (0.07 D/E) provide a massive cushion for volatility. Despite bearish insider sentiment and short-term technical weakness, the long-term growth trajectory remains exceptionally strong.